Court Records: Drug and Market Challenges

court records: U.S. court records in the case against an immigrant billionaire who is one of Arizona's wealthiest men describe the daunting market challenges that Insys Therapeutics founder John N. Kapoor and fellow executives faced after launching the opioid medication Subsys in 2012, according to The Chronicle Herald. The highly addictive drug was going to cost a cancer patient up to thousands of dollars a month to control intolerable levels of pain. So drug company executives moved quickly to make its production worthwhile. It could only be prescribed by a medical practitioner registered with the Drug Enforcement Administration, and it was among several cancer pain medicines already available. Defence attorney Brian T. Kelly, a high-profile Boston lawyer, has said Kapoor is not guilty. Five years later, Subsys is at the heart of the case against Insys Therapeutics executives, including Kapoor, 74, of Phoenix, who is charged with leading a nationwide conspiracy to bribe doctors and pharmacists to widely prescribe the potent painkiller to people who didn't need it. (www.immigrantscanada.com). As reported in the news.